November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Pharmaceuticals, Biotechnology and Life Sciences
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor